VA

DRUG4 trials

Sponsors

United States Department of Agriculture (USDA), JW Pharmaceutical, The First Affiliated Hospital of Soochow University, Nanfang Hospital, Southern Medical University

Conditions

Acute Myeloid Leukemia, AdultCardiovascular DiseaseDyslipidemiaHypertensionNewly DiagnosedNewly Diagnosed Acute Myeloid Leukemia With High Risk

Phase 2

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia

RecruitingNCT06532552

The First Affiliated Hospital of Soochow UniversityAcute Myeloid Leukemia, Adult, Newly Diagnosed

Start: 2024-07-29End: 2028-08-01Target: 172Updated: 2025-11-19

Phase 3

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

CompletedNCT05331014

JW PharmaceuticalDyslipidemia, Hypertension

Start: 2021-11-15End: 2022-11-08Updated: 2024-03-15

HVA vs IA/DA or VA in the Treatment of ND HR-AML

RecruitingNCT06810791

Nanfang Hospital, Southern Medical UniversityNewly Diagnosed Acute Myeloid Leukemia With High Risk

Start: 2025-01-01End: 2026-12-31Target: 876Updated: 2025-02-06

Unknown Phase

Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease

CompletedNCT00942656

United States Department of Agriculture (USDA)Cardiovascular Disease

Start: 2009-02-28End: 2009-09-30Target: 120Updated: 2011-02-09

Related Papers

Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial.

2015-11-1158 citations